Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Whiteness HP Automixx is a professional, in-office dental bleaching system formulated with 35% hydrogen peroxide. Developed by FGM Dental Group, the product features an automixing syringe system that ensures a precise and consistent ratio of the peroxide gel to the catalyst/thickener. The formulation is notably enriched with calcium to assist in the maintenance of enamel integrity and to minimize mineral loss during the whitening process. Its primary therapeutic action involves the penetration of the tooth structure to oxidize organic pigments. It is indicated for the treatment of both vital and non-vital teeth affected by extrinsic or intrinsic stains, including those caused by age, smoking, or dietary habits.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Whiteness HP Automixx.